The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)



Gene Review

RBM39  -  RNA binding motif protein 39

Homo sapiens

Synonyms: CAPER, CAPER alpha, CAPERalpha, CC1.3, FSAP59, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of RBM39


Psychiatry related information on RBM39


High impact information on RBM39


Chemical compound and disease context of RBM39


Biological context of RBM39


Anatomical context of RBM39


Associations of RBM39 with chemical compounds


Physical interactions of RBM39


Enzymatic interactions of RBM39


Regulatory relationships of RBM39


Other interactions of RBM39


Analytical, diagnostic and therapeutic context of RBM39


  1. The utility of estrogen receptor and progesterone receptor immunohistochemistry in the distinction of metastatic breast carcinoma from other tumors in the liver. Nash, J.W., Morrison, C., Frankel, W.L. Arch. Pathol. Lab. Med. (2003) [Pubmed]
  2. Estrogen receptor alpha polymorphisms associated with susceptibility to hepatocellular carcinoma in hepatitis B virus carriers. Zhai, Y., Zhou, G., Deng, G., Xie, W., Dong, X., Zhang, X., Yu, L., Yang, H., Yuan, X., Zhang, H., Zhi, L., Yao, Z., Shen, Y., Qiang, B., He, F. Gastroenterology (2006) [Pubmed]
  3. Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California. Yu, M.C., Tong, M.J., Govindarajan, S., Henderson, B.E. J. Natl. Cancer Inst. (1991) [Pubmed]
  4. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Fattovich, G., Stroffolini, T., Zagni, I., Donato, F. Gastroenterology (2004) [Pubmed]
  5. Elevated serum testosterone levels and risk of hepatocellular carcinoma. Yu, M.W., Chen, C.J. Cancer Res. (1993) [Pubmed]
  6. Treatment of hepatocellular carcinoma with combined suppression and inhibition of sex hormones: a randomized, controlled trial. Manesis, E.K., Giannoulis, G., Zoumboulis, P., Vafiadou, I., Hadziyannis, S.J. Hepatology (1995) [Pubmed]
  7. Establishment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues. Sun, F.X., Tang, Z.Y., Lui, K.D., Ye, S.L., Xue, Q., Gao, D.M., Ma, Z.C. Int. J. Cancer (1996) [Pubmed]
  8. Hepatitis B virus immunopathogenesis. Chisari, F.V., Ferrari, C. Annu. Rev. Immunol. (1995) [Pubmed]
  9. Molecular pathogenesis of human hepatocellular carcinoma. Thorgeirsson, S.S., Grisham, J.W. Nat. Genet. (2002) [Pubmed]
  10. TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer. Kuramochi, M., Fukuhara, H., Nobukuni, T., Kanbe, T., Maruyama, T., Ghosh, H.P., Pletcher, M., Isomura, M., Onizuka, M., Kitamura, T., Sekiya, T., Reeves, R.H., Murakami, Y. Nat. Genet. (2001) [Pubmed]
  11. Variant estrogen receptor messenger RNA species detected in human primary hepatocellular carcinoma. Villa, E., Camellini, L., Dugani, A., Zucchi, F., Grottola, A., Merighi, A., Buttafoco, P., Losi, L., Manenti, F. Cancer Res. (1995) [Pubmed]
  12. Oxidative DNA damage in circulating leukocytes occurs as an early event in chronic HCV infection. Farinati, F., Cardin, R., Degan, P., De Maria, N., Floyd, R.A., Van Thiel, D.H., Naccarato, R. Free Radic. Biol. Med. (1999) [Pubmed]
  13. Tamoxifen inhibits hepatoma cell growth through an estrogen receptor independent mechanism. Jiang, S.Y., Shyu, R.Y., Yeh, M.Y., Jordan, V.C. J. Hepatol. (1995) [Pubmed]
  14. Ah receptor mediating induction of cytochrome P450IA1 in a novel continuous human liver cell line (Mz-Hep-1). Detection by binding with [3H]2,3,7,8-tetrachlorodibenzo-p-dioxin and relationship to the activity of aryl hydrocarbon hydroxylase. Roberts, E.A., Johnson, K.C., Dippold, W.G. Biochem. Pharmacol. (1991) [Pubmed]
  15. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group. Muto, Y., Moriwaki, H., Ninomiya, M., Adachi, S., Saito, A., Takasaki, K.T., Tanaka, T., Tsurumi, K., Okuno, M., Tomita, E., Nakamura, T., Kojima, T. N. Engl. J. Med. (1996) [Pubmed]
  16. DNA methylation and environmental exposures in human hepatocellular carcinoma. Shen, L., Ahuja, N., Shen, Y., Habib, N.A., Toyota, M., Rashid, A., Issa, J.P. J. Natl. Cancer Inst. (2002) [Pubmed]
  17. Estrogen receptor levels and lipid peroxidation in hepatocellular carcinoma with hepatitis C virus infection. Shimizu, I., Inoue, H., Yano, M., Shinomiya, H., Wada, S., Tsuji, Y., Tsutsui, A., Okamura, S., Shibata, H., Ito, S. Liver (2001) [Pubmed]
  18. Clinicopathologic comparisons between estrogen receptor-positive and -negative hepatocellular carcinomas. Nagasue, N., Kohno, H., Chang, Y.C., Yamanoi, A., Nakamura, T., Yukaya, H., Hayashi, T. Ann. Surg. (1990) [Pubmed]
  19. Overexpression of metastatic tumor antigen 1 in hepatocellular carcinoma: Relationship to vascular invasion and estrogen receptor-alpha. Moon, W.S., Chang, K., Tarnawski, A.S. Hum. Pathol. (2004) [Pubmed]
  20. Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesis. Shuda, M., Kondoh, N., Imazeki, N., Tanaka, K., Okada, T., Mori, K., Hada, A., Arai, M., Wakatsuki, T., Matsubara, O., Yamamoto, N., Yamamoto, M. J. Hepatol. (2003) [Pubmed]
  21. Production of hydrogen peroxide in cancerous tissue by intravenous administration of sodium 5,6-benzylidene-L-ascorbate. Asano, K., Satoh, K., Hosaka, M., Arakawa, H., Inagaki, M., Hisamitsu, T., Maeda, M., Kochi, M., Sakagami, H. Anticancer Res. (1999) [Pubmed]
  22. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Lee, J.S., Heo, J., Libbrecht, L., Chu, I.S., Kaposi-Novak, P., Calvisi, D.F., Mikaelyan, A., Roberts, L.R., Demetris, A.J., Sun, Z., Nevens, F., Roskams, T., Thorgeirsson, S.S. Nat. Med. (2006) [Pubmed]
  23. High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multicenter randomized controlled trial. Chow, P.K., Tai, B.C., Tan, C.K., Machin, D., Win, K.M., Johnson, P.J., Soo, K.C. Hepatology (2002) [Pubmed]
  24. Variant estrogen receptors and their role in liver disease. Villa, E., Colantoni, A., Grottola, A., Ferretti, I., Buttafoco, P., Bertani, H., De Maria, N., Manenti, F. Mol. Cell. Endocrinol. (2002) [Pubmed]
  25. Progesterone receptor in hepatocellular carcinoma. Correlation with androgen and estrogen receptors. Nagasue, N., Kohno, H., Yamanoi, A., Kimoto, T., Chang, Y.C., Nakamura, T. Cancer (1991) [Pubmed]
  26. Decreased expression of B7 costimulatory molecules and major histocompatibility complex class-I in human hepatocellular carcinoma. Fujiwara, K., Higashi, T., Nouso, K., Nakatsukasa, H., Kobayashi, Y., Uemura, M., Nakamura, S., Sato, S., Hanafusa, T., Yumoto, Y., Naito, I., Shiratori, Y. J. Gastroenterol. Hepatol. (2004) [Pubmed]
  27. Aberrant p16INK4A RNA transcripts expressed in hepatocellular carcinoma cell lines regulate pRb phosphorylation by binding with CDK4, resulting in delayed cell cycle progression. Cho, J.W., Jeong, Y.W., Han, S.W., Park, J.B., Jang, B.C., Baek, W.K., Kwon, T.K., Park, J.W., Kim, S.P., Suh, M.H., Suh, S.I. Liver Int. (2003) [Pubmed]
  28. Absence of APOBEC-1 mediated mRNA editing in human carcinomas. Greeve, J., Lellek, H., Apostel, F., Hundoegger, K., Barialai, A., Kirsten, R., Welker, S., Greten, H. Oncogene (1999) [Pubmed]
  29. Carcinoembryonic antigen and lectin binding in the bile canalicular structures of hepatocellular carcinoma. Machinami, R., Oono, Y. Virchows Archiv. A, Pathological anatomy and histopathology. (1987) [Pubmed]
  30. Impact of PTEN expression on the outcome of hepatitis C virus-positive cirrhotic hepatocellular carcinoma patients: possible relationship with COX II and inducible nitric oxide synthase. Rahman, M.A., Kyriazanos, I.D., Ono, T., Yamanoi, A., Kohno, H., Tsuchiya, M., Nagasue, N. Int. J. Cancer (2002) [Pubmed]
  31. EGFR is phosphorylated at Ty845 in hepatocellular carcinoma. Kannangai, R., Sahin, F., Torbenson, M.S. Mod. Pathol. (2006) [Pubmed]
  32. Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells. Kim, T.Y., Jong, H.S., Song, S.H., Dimtchev, A., Jeong, S.J., Lee, J.W., Kim, T.Y., Kim, N.K., Jung, M., Bang, Y.J. Oncogene (2003) [Pubmed]
  33. Expression of Aurora-B kinase and phosphorylated histone H3 in hepatocellular carcinoma. Sistayanarain, A., Tsuneyama, K., Zheng, H., Takahashi, H., Nomoto, K., Cheng, C., Murai, Y., Tanaka, A., Takano, Y. Anticancer Res. (2006) [Pubmed]
  34. Opposing action of estrogen receptors alpha and beta on tumor necrosis factor-alpha gene expression and caspase-8-mediated apoptotic effects in HA22T cells. Huang, E.J., Wu, C.C., Lee, S.D., Chen, J.H., Liu, J.Y., Ko, J.L., Lin, J.A., Lu, M.C., Chen, L.M., Huang, C.Y., Kuo, W.W. Mol. Cell. Biochem. (2006) [Pubmed]
  35. The clinical and pathogenetic significance of estrogen receptor-beta expression in chronic liver diseases and liver carcinoma. Iavarone, M., Lampertico, P., Seletti, C., Francesca Donato, M., Ronchi, G., del Ninno, E., Colombo, M. Cancer (2003) [Pubmed]
  36. Disrupted IGF2 promoter control by silencing of promoter P1 in human hepatocellular carcinoma. Li, X., Nong, Z., Ekström, C., Larsson, E., Nordlinder, H., Hofmann, W.J., Trautwein, C., Odenthal, M., Dienes, H.P., Ekström, T.J., Schirmacher, P. Cancer Res. (1997) [Pubmed]
  37. Expression and function of CXC and CC chemokines in human malignant liver tumors: a role for human monokine induced by gamma-interferon in lymphocyte recruitment to hepatocellular carcinoma. Yoong, K.F., Afford, S.C., Jones, R., Aujla, P., Qin, S., Price, K., Hubscher, S.G., Adams, D.H. Hepatology (1999) [Pubmed]
  38. Pegylated Recombinant Human Arginase (rhArg-peg5,000mw) Inhibits the In vitro and In vivo Proliferation of Human Hepatocellular Carcinoma through Arginine Depletion. Cheng, P.N., Lam, T.L., Lam, W.M., Tsui, S.M., Cheng, A.W., Lo, W.H., Leung, Y.C. Cancer Res. (2007) [Pubmed]
  39. Glucocorticoid receptors in hepatocellular carcinoma and adjacent liver tissue. P'eng, F.K., Lui, W.Y., Chang, T.J., Kao, H.L., Wu, L.H., Liu, T.Y., Chi, C.W. Cancer (1988) [Pubmed]
  40. Resistance to p53-mediated growth arrest and apoptosis in Hep 3B hepatoma cells. Friedman, S.L., Shaulian, E., Littlewood, T., Resnitzky, D., Oren, M. Oncogene (1997) [Pubmed]
  41. Better survival in women with resected hepatocellular carcinoma is not related to tumor proliferation or expression of hormone receptors. Ng, I.O., Ng, M., Fan, S.T. Am. J. Gastroenterol. (1997) [Pubmed]
  42. Hormonal treatment of human hepatocellular carcinoma. Di Maio, M., De Maio, E., Morabito, A., D'Aniello, R., De Feo, G., Gallo, C., Perrone, F. Ann. N. Y. Acad. Sci. (2006) [Pubmed]
  43. Tamoxifen for the treatment of malignancies other than breast and endometrial carcinoma. Gelmann, E.P. Semin. Oncol. (1997) [Pubmed]
WikiGenes - Universities